Acceleron Pharma Inc.
XLRN
|
NASDAQ
|
0 Followers
Company Quality
Profitability Score
17/100
Solvency Score
25/100
Dividends
Dividends data currently unavailable.Earnings
Earnings data currently unavailable.My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sector
Biotechnology
Industry
Mr. Habib Dable
CEO
312
Employees
Cambridge
Headquarters
US
Country
Key Metrics TTM
Valuation
Market cap.
$0Enterprise Value
-$647MPrice to Earnings
-61.15Price to Sales
0.00Price to Book
11.87Price to Cash Flow
0.00Profitability
Return on Assets
-17.81%Return on Equity
-25.45%Return on Invested Capital
-19.03%Gross Margin
100.00%Operating Margin
-180.83%Net Margin
-179.45%Liquidity
Quick Ratio
14.85Current Ratio
14.85Cash Ratio
11.15Inventory Turnover
0.00Asset Turnover
0.10Total Liabilities
N/ASolvency
Debt to Assets
0.03Debt to Equity
N/AInterest Coverage
0.00Equity Ratio
N/ALong-term Debt to Cap.
0.00Altman Z-Score
N/APerformance
Performance data currently unavailable.
Earnings Waterfall
Earnings data currently unavailable.
Debt level and coverage
Debt level and coverage data currently unavailable.
Earnings
Feed
There are no posts to show right now.